Insurance News
Regulatory updates in plain English
Stay current with the latest from CMS, state departments of insurance, NAIC, the Federal Register, and Congress — rewritten so you can actually understand what it means for your practice.
CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
The Centers for Medicare & Medicaid Services (CMS) has announced that drug manufacturers will participate in the third round of negotiations for Medicare drug prices. This change affects pharmaceutical companies that provide medications covered under Medicare. Agents should stay informed about these...
CMS Strengthens Patient Protections and Accountability in Organ Donation System
The Centers for Medicare & Medicaid Services (CMS) has updated its guidelines to improve protections for patients and their families involved in the organ donation process. This change aims to ensure that patients' rights are better safeguarded and that the organ donation system is more accountable....
CMS Proposes Regulations to Lower Health Care Costs, Expand Consumer Choice, and Protect Taxpayers
The Centers for Medicare & Medicaid Services (CMS) has proposed new rules aimed at lowering health care costs and improving choices for consumers. These changes will affect health insurance agents and brokers by increasing accountability and reducing fraud in the industry. The goal is to make health...
CMS to Lower Drug Costs and Improve Care by Extending Deadline for GENEROUS Model Application
The Centers for Medicare & Medicaid Services (CMS) has extended the application deadline for drug manufacturers to join the GENEROUS Model, which aims to reduce drug costs and improve care in Medicaid. The new deadline is now April 30, 2026, instead of March 31, 2026. This change allows more drug co...
CMS Announces Manufacturer Participation in Third Cycle of Medicare Drug Price Negotiation
The Centers for Medicare & Medicaid Services (CMS) has announced that drug companies are participating in the third round of negotiations for Medicare drug prices. This affects 15 specific high-cost drugs that are covered under Medicare Part B and Part D. These negotiations aim to lower the prices o...
CMS to Lower Drug Costs and Improve Care by Extending Deadline for GENEROUS Model Application
The Centers for Medicare & Medicaid Services (CMS) has extended the application deadline for drug manufacturers to join the GENEROUS Model, which aims to reduce drug costs in Medicaid and improve healthcare access. The new deadline is now April 30, 2026, giving manufacturers more time to apply. This...
CMS Strengthens Patient Protections and Accountability in Organ Donation System
The Centers for Medicare & Medicaid Services (CMS) has introduced new guidelines to improve the organ donation process, ensuring that patients and their families receive respectful and compassionate care. These guidelines clarify that hospitals must provide full medical treatment to all patients, re...
CMS Proposes Regulations to Lower Health Care Costs, Expand Consumer Choice, and Protect Taxpayers
The Centers for Medicare & Medicaid Services (CMS) has proposed new rules aimed at lowering health care costs and improving choices for consumers. These changes will affect health insurance agents and brokers by tightening regulations to prevent fraud and ensure that taxpayer-funded subsidies are us...